Rare Kidney Disease Drug Development Agenda & Speakers

The 6th Rare & Genetic Kidney Disease Drug Development Summit is your unique forum to learn, network and partner with the brightest minds revolutionizing the industry.

Here’s a preview of what’s inside:

3 Days of Insights from Leading Renal Innovators

Hear how organizations, including Takeda, Maze Therapeutics, and Walden Biosciences, are refining strategies, prioritizing assets, and staying ahead in rare kidney disease development.

6+ Hours of Dedicated Networking Sessions

See how the summit can support you in building industry partnerships, helping you discover new targets, novel translational technologies, patient recruitment, and real-world data strategies to advance kidney disease pipelines.

5+ Key Disease Indications Covered

Explore comprehensive coverage of IgAN, FSGS, ADPKD, Alport syndrome, and C3G, with tailored insights into the unique developmental challenges in each.